GlassScriptPhysician profile
Mitra Ayazifar
NPI 1972520641
$2,013.98
in general payments reported to CMS, 2019-2025
21 companies · $57.91 in 2025
The $57.91 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $272 · 2021: $305 · 2022: $436 · 2023: $434 · 2024: $226 · 2025: $57.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $338.35 | 2019-2023 | |
| Sun Pharmaceutical Industries INC. | $169.63 | 2020-2024 | |
| Alcon Vision LLC | $157.85 | 2019-2024 | Argos |
| Novartis Pharmaceuticals Corporation | $143.91 | 2019-2022 | |
| Horizon Therapeutics Plc | $136.37 | 2021-2023 | Tepezza |
| Sight Sciences, INC. | $135.28 | 2021-2025 | Sion Surgical Instrument, Omni Surgical System |
| Coopervision INC. | $124.34 | 2020-2023 | Misight Contact Lens |
| Mallinckrodt Hospital Products INC. | $109.59 | 2022-2024 | Acthar |
| Dompe US, INC. | $89.84 | 2022-2025 | Oxervate |
| Bausch & Lomb Americas INC. | $78.13 | 2023 | Miebo |
| Oyster Point Pharma, INC. | $75.74 | 2022-2023 | Tyrvaya |
| Johnson & Johnson Surgical Vision, INC. | $75.18 | 2021-2022 | |
| Merz North America, INC. | $75.00 | 2023 | Xeomin |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $71.93 | 2019-2020 | |
| Allergan, INC. | $62.65 | 2020-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $43.76 | 2022-2023 | Vuity |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Johnson & Johnson Vision Care, INC. | $29.23 | 2020 | |
| Rxsight INC | $25.00 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Glaukos Corporation | $17.73 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $15.67 | 2024 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitra Ayazifar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.